Advertisement
Screener

INSULET CORPORATION (PODD) Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest

2.8 / 5 stars · 68/120 Roast Me

INSULET CORPORATION Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest

INSULET CORPORATION (PODD) reported Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest of -$28.40 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-06.

Discontinued › Income Statement › Other Income

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments · last filed 2021-08-06

  • INSULET CORPORATION income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for the quarter ending 2021-06-30 was -$28.40M, a 263.22% decline year-over-year.
  • INSULET CORPORATION income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for the quarter ending 2021-03-31 was $300.00K.
  • INSULET CORPORATION income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for the quarter ending 2020-12-31 was -$18.50M, a 372.06% decline year-over-year.
  • INSULET CORPORATION income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for the quarter ending 2020-09-30 was $13.40M, a 1118.18% increase year-over-year.
  • INSULET CORPORATION income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for fiscal 2020 was $9.70M, a 33.10% decline from fiscal 2019.
  • INSULET CORPORATION income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for fiscal 2019 was $14.50M, a 178.85% increase from fiscal 2018.
  • INSULET CORPORATION income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for fiscal 2018 was $5.20M.
  • INSULET CORPORATION income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for fiscal 2017 was -$26.60M.
Period endIncome (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 3 monthIncome (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 3 month as first filedIncome (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 6 monthIncome (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 6 month as first filedIncome (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 9 monthIncome (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 9 month as first filedIncome (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 12 monthIncome (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 12 month as first filed
2021-06-30-$28.40M
10-Q · filed 2021-08-06
-$28.10M
10-Q · filed 2021-08-06
-$46.60M
derived: sum of 3 quarters · filed 2021-08-06
-$33.20M
derived: sum of 4 quarters · filed 2021-08-06
2021-03-31$300.00K
10-Q · filed 2021-05-07
-$18.20M
derived: sum of 2 quarters · filed 2021-05-07
-$4.80M
derived: sum of 3 quarters · filed 2021-05-07
$12.60M
derived: sum of 4 quarters · filed 2021-08-06
2020-12-31-$18.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
-$5.10M
derived: sum of 2 quarters · filed 2021-02-24
$12.30M
derived: sum of 3 quarters · filed 2021-08-06
$9.70M
10-K · filed 2021-02-24
2020-09-30$13.40M
10-Q · filed 2020-11-05
$30.80M
derived: sum of 2 quarters · filed 2021-08-06
$28.20M
10-Q · filed 2020-11-05
$35.00M
derived: sum of 4 quarters · filed 2021-08-06
2020-06-30$17.40M
10-Q · filed 2021-08-06
$14.80M
10-Q · filed 2021-08-06
$21.60M
derived: sum of 3 quarters · filed 2021-08-06
$22.70M
derived: sum of 4 quarters · filed 2021-08-06
2020-03-31-$2.60M
10-Q · filed 2021-05-07
$4.20M
derived: sum of 2 quarters · filed 2021-05-07
$5.30M
derived: sum of 3 quarters · filed 2021-05-07
$7.20M
derived: sum of 4 quarters · filed 2021-05-07
2019-12-31$6.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$7.90M
derived: sum of 2 quarters · filed 2021-02-24
$9.80M
derived: sum of 3 quarters · filed 2021-02-24
$14.50M
10-K · filed 2021-02-24
2019-09-30$1.10M
10-Q · filed 2020-11-05
$1.13M
10-Q · filed 2019-11-06
$3.00M
derived: sum of 2 quarters · filed 2020-11-05
$7.70M
10-Q · filed 2020-11-05
$7.72M
10-Q · filed 2019-11-06
$18.56M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$1.90M
10-Q · filed 2020-08-07
$1.88M
10-Q · filed 2019-08-06
$6.60M
10-Q · filed 2020-08-07
$6.59M
10-Q · filed 2019-08-06
$17.46M
derived: sum of 3 quarters · filed 2021-02-24
$19.32M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$4.70M
10-Q · filed 2020-05-08
$4.70M
10-Q · filed 2019-05-03
$15.56M
derived: sum of 2 quarters · filed 2021-02-24
$17.41M
derived: sum of 3 quarters · filed 2021-02-24
$16.14M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$10.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$12.71M
derived: sum of 2 quarters · filed 2021-02-24
$11.44M
derived: sum of 3 quarters · filed 2021-02-24
$5.20M
10-K · filed 2021-02-24
$5.23M
10-K · filed 2019-02-26
2018-09-30$1.85M
10-Q · filed 2019-11-06
$574.00K
derived: sum of 2 quarters · filed 2019-11-06
-$5.66M
10-Q · filed 2019-11-06
-$12.61M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30-$1.28M
10-Q · filed 2019-08-06
-$7.51M
10-Q · filed 2019-08-06
-$14.46M
derived: sum of 3 quarters · filed 2020-02-26
-$16.57M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31-$6.24M
10-Q · filed 2019-05-03
-$13.18M
derived: sum of 2 quarters · filed 2020-02-26
-$15.29M
derived: sum of 3 quarters · filed 2020-02-26
-$22.95M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31-$6.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
-$9.05M
derived: sum of 2 quarters · filed 2020-02-26
-$16.72M
derived: sum of 3 quarters · filed 2020-02-26
-$26.60M
10-K · filed 2020-02-26
-$26.57M
10-K · filed 2018-02-22
2017-09-30-$2.11M
10-Q · filed 2018-11-02
-$9.77M
derived: sum of 2 quarters · filed 2018-11-02
-$19.65M
10-Q · filed 2018-11-02
-$28.61M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30-$7.67M
10-Q · filed 2018-08-02
-$17.55M
10-Q · filed 2018-08-02
-$26.50M
derived: sum of 3 quarters · filed 2019-02-26
-$29.45M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31-$9.88M
10-Q · filed 2018-05-04
-$18.84M
derived: sum of 2 quarters · filed 2019-02-26
-$21.79M
derived: sum of 3 quarters · filed 2019-02-26
-$26.07M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31-$8.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
-$11.91M
derived: sum of 2 quarters · filed 2019-02-26
-$16.19M
derived: sum of 3 quarters · filed 2019-02-26
-$26.82M
10-K · filed 2019-02-26
2016-09-30-$2.95M
10-Q · filed 2017-11-03
-$7.24M
derived: sum of 2 quarters · filed 2017-11-03
-$17.86M
10-Q · filed 2017-11-03
-$33.64M
derived: sum of 4 quarters · filed 2018-02-22
2016-06-30-$4.29M
10-Q · filed 2017-08-04
-$14.91M
10-Q · filed 2017-08-04
-$30.69M
derived: sum of 3 quarters · filed 2018-02-22
-$48.63M
derived: sum of 4 quarters · filed 2018-02-22
2016-03-31-$10.63M
10-Q · filed 2017-05-09
-$26.40M
derived: sum of 2 quarters · filed 2018-02-22
-$44.34M
derived: sum of 3 quarters · filed 2018-02-22
-$61.60M
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31-$15.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
-$33.72M
derived: sum of 2 quarters · filed 2018-02-22
-$50.97M
derived: sum of 3 quarters · filed 2018-02-22
-$61.39M
10-K · filed 2018-02-22
-$73.23M
10-K · filed 2016-02-29
2015-09-30-$17.94M
10-Q · filed 2016-11-04
-$18.86M
10-Q · filed 2015-11-06
-$35.19M
derived: sum of 2 quarters · filed 2016-11-04
-$45.61M
10-Q · filed 2016-11-04
-$46.04M
10-Q · filed 2015-11-06
-$47.53M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30-$17.25M
10-Q · filed 2016-08-04
-$15.39M
10-Q · filed 2015-08-12
-$27.67M
10-Q · filed 2016-08-04
-$27.18M
10-Q · filed 2015-08-12
-$29.59M
derived: sum of 3 quarters · filed 2017-02-28
-$40.41M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31-$10.42M
10-Q · filed 2016-04-29
-$11.78M
10-Q · filed 2015-04-30
-$12.34M
derived: sum of 2 quarters · filed 2017-02-28
-$23.16M
derived: sum of 3 quarters · filed 2017-02-28
-$52.22M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31-$1.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
-$12.74M
derived: sum of 2 quarters · filed 2017-02-28
-$41.80M
derived: sum of 3 quarters · filed 2017-02-28
-$47.88M
10-K · filed 2017-02-28
-$51.36M
10-K · filed 2015-02-26
2014-09-30-$10.82M
10-Q · filed 2015-11-06
-$39.88M
derived: sum of 2 quarters · filed 2015-11-06
-$45.96M
10-Q · filed 2015-11-06
-$46.20M
derived: sum of 4 quarters · filed 2016-09-06
2014-06-30-$29.06M
10-Q · filed 2015-08-12
-$35.14M
10-Q · filed 2015-08-12
-$35.38M
derived: sum of 3 quarters · filed 2016-09-06
-$56.66M
derived: sum of 4 quarters · filed 2016-09-06
2014-03-31-$6.08M
10-Q · filed 2015-04-30
-$6.32M
derived: sum of 2 quarters · filed 2016-09-06
-$27.60M
derived: sum of 3 quarters · filed 2016-09-06
-$38.00M
derived: sum of 4 quarters · filed 2016-09-06
2013-12-31-$238.00K
derived: 8-K 12 month − 10-Q 9 month · filed 2016-09-06
-$21.52M
derived: sum of 2 quarters · filed 2016-09-06
-$31.92M
derived: sum of 3 quarters · filed 2016-09-06
-$42.46M
8-K · filed 2016-09-06
-$44.87M
10-K · filed 2014-02-28
2013-09-30-$21.29M
10-Q · filed 2014-11-05
-$31.69M
derived: sum of 2 quarters · filed 2014-11-05
-$42.22M
10-Q · filed 2014-11-05
-$52.34M
derived: sum of 4 quarters · filed 2015-02-26
2013-06-30-$10.40M
10-Q · filed 2014-08-07
-$20.93M
10-Q · filed 2014-08-07
-$31.06M
derived: sum of 3 quarters · filed 2015-02-26
-$43.45M
derived: sum of 4 quarters · filed 2015-02-26
2013-03-31-$10.53M
10-Q · filed 2014-05-07
-$20.66M
derived: sum of 2 quarters · filed 2015-02-26
-$33.05M
derived: sum of 3 quarters · filed 2015-02-26
-$47.45M
derived: sum of 4 quarters · filed 2015-02-26
2012-12-31-$10.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26
-$22.51M
derived: sum of 2 quarters · filed 2015-02-26
-$36.92M
derived: sum of 3 quarters · filed 2015-02-26
-$51.66M
10-K · filed 2015-02-26
2012-09-30-$12.39M
10-Q · filed 2013-11-07
-$26.80M
derived: sum of 2 quarters · filed 2013-11-07
-$41.53M
10-Q · filed 2013-11-07
-$55.74M
derived: sum of 4 quarters · filed 2014-02-28
2012-06-30-$14.41M
10-Q · filed 2013-08-08
-$29.14M
10-Q · filed 2013-08-08
-$43.35M
derived: sum of 3 quarters · filed 2014-02-28
-$56.91M
derived: sum of 4 quarters · filed 2014-02-28
2012-03-31-$14.73M
10-Q · filed 2013-05-08
-$28.95M
derived: sum of 2 quarters · filed 2014-02-28
-$42.51M
derived: sum of 3 quarters · filed 2014-02-28
-$61.93M
derived: sum of 4 quarters · filed 2014-02-28
2011-12-31-$14.21M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-02-28
-$27.77M
derived: sum of 2 quarters · filed 2014-02-28
-$47.20M
derived: sum of 3 quarters · filed 2014-02-28
-$57.04M
10-K · filed 2014-02-28
2011-09-30-$13.56M
10-Q/A · filed 2013-02-28
-$32.98M
derived: sum of 2 quarters · filed 2013-02-28
-$42.83M
10-Q/A · filed 2013-02-28
2011-06-30-$19.42M
10-Q/A · filed 2013-02-28
-$29.27M
10-Q/A · filed 2013-02-28
2011-03-31-$9.85M
10-Q/A · filed 2013-02-28
2010-12-31-$61.16M
10-K/A · filed 2013-02-28
2009-12-31-$72.34M
10-K/A · filed 2013-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
GLAUKOS Corp (GKOS)United States$9.135B-43.73
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
Penumbra Inc (PEN)United States$12.596B77.33
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85